221 related articles for article (PubMed ID: 27661436)
1. HPLC method development, validation, and impurity characterization of a potent antitumor nucleoside, T-dCyd (NSC 764276).
Liu M; Wang J; Liu P
J Pharm Biomed Anal; 2016 Nov; 131():429-435. PubMed ID: 27661436
[TBL] [Abstract][Full Text] [Related]
2. HPLC method development, validation, and impurity characterization of a potent antitumor indenoisoquinoline, LMP776 (NSC 725776).
Wang J; Liu M; Yang C; Wu X; Wang E; Liu P
J Pharm Biomed Anal; 2016 May; 124():267-273. PubMed ID: 26970596
[TBL] [Abstract][Full Text] [Related]
3. HPLC method development, validation and impurity characterization for an antitumor Hsp90 inhibitor-PU-H71 (NSC 750424).
Liu M; Wang J; Wu X; Wang E; Baptista D; Scott B; Liu P
J Pharm Biomed Anal; 2014 Feb; 89():34-41. PubMed ID: 24252723
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
5. Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS/MS.
Mahamuni BS; Jajula A; Awasthi A; Kalariya PD; Talluri MV
J Pharm Biomed Anal; 2016 Jun; 125():219-28. PubMed ID: 27037978
[TBL] [Abstract][Full Text] [Related]
6. Structural elucidation of the impurities in Enzalutamide bulk drug and the development, validation of corresponding HPLC method.
Ma X; Zhou W; Zou Q; Ouyang P
J Pharm Biomed Anal; 2016 Nov; 131():436-443. PubMed ID: 27664386
[TBL] [Abstract][Full Text] [Related]
7. Characterization, HPLC method development and impurity identification for 3,4,3-LI(1,2-HOPO), a potent actinide chelator for radionuclide decorporation.
Liu M; Wang J; Wu X; Wang E; Abergel RJ; Shuh DK; Raymond KN; Liu P
J Pharm Biomed Anal; 2015 Jan; 102():443-9. PubMed ID: 25459944
[TBL] [Abstract][Full Text] [Related]
8. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
[TBL] [Abstract][Full Text] [Related]
9. Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development.
Stolarczyk EU; Rosa A; Kubiszewski M; Zagrodzka J; Cybulski M; Kaczmarek Ł
Eur J Pharm Sci; 2017 Nov; 109():389-401. PubMed ID: 28865686
[TBL] [Abstract][Full Text] [Related]
10. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
Kalariya PD; Talluri MV; Patel PN; Srinivas R
J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
[TBL] [Abstract][Full Text] [Related]
11. Gradient RP-HPLC method for the determination of potential impurities in atazanavir sulfate.
Chitturi SR; Somannavar YS; Peruri BG; Nallapati S; Sharma HK; Budidet SR; Handa VK; Vurimindi HB
J Pharm Biomed Anal; 2011 Apr; 55(1):31-47. PubMed ID: 21316175
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a stability-indicating liquid chromatographic method for determination of emtricitabine and related impurities in drug substance.
Seshachalam U; Haribabu B; Chandrasekhar KB
J Sep Sci; 2007 May; 30(7):999-1004. PubMed ID: 17566333
[TBL] [Abstract][Full Text] [Related]
13. Degradation pathways and impurity profiling of the anticancer drug apalutamide by HPLC and LC-MS/MS and separation of impurities using Design of Experiments.
Lakka NS; Kuppan C; Vadagam N; Reddamoni SY; Muthusamy C
Biomed Chromatogr; 2023 Feb; 37(2):e5549. PubMed ID: 36409057
[TBL] [Abstract][Full Text] [Related]
14. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
15. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
[TBL] [Abstract][Full Text] [Related]
17. Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.
Prajapati KJ; Kothari CS
Chem Res Toxicol; 2022 Jul; 35(7):1206-1219. PubMed ID: 35731702
[TBL] [Abstract][Full Text] [Related]
18. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
[TBL] [Abstract][Full Text] [Related]
19. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
Bhardwaj SP; Singh S
J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS characterization of forced degradation products of zofenopril.
Ramesh T; Nageswara Rao P; Nageswara Rao R
J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
